SCHEMBL18555352

SCHEMBL18555352

COCN1CCCC1C(N)=O

nearest known ligand 0.40

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SPHK1 Q9NYA1 1/20 0.40
SCN3A Q9NY46 1/20 0.39
POLB P06746 1/20 0.39
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38
DPP4 P27487 1/20 0.36
LMNA P02545 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.35
GAA P10253 1/20 0.34
CD274 Q9NZQ7 2/20 0.34
PDCD1 Q15116 1/20 0.33
RAB9A P51151 1/20 0.33
HTR1A P08908 1/20 0.33
HTR7 P34969 1/20 0.33
KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4555126 1.00 SPHK1 (0.40) SPHK1SCN3APOLBMAOAMAOB
SCHEMBL2038078 0.84 SMN1; SMN2 (0.47) LMNASMN1; SMN2RAB9AKDM4E
SCHEMBL13555216 0.84 SMN1; SMN2 (0.47) LMNASMN1; SMN2RAB9AKDM4E
SCHEMBL30639643 0.83 LTA4H (0.41) SPHK1SCN3APOLBMAOAMAOB
SCHEMBL14155228 0.80 SCN3A (0.39) SPHK1SCN3APOLBMAOAMAOB
SCHEMBL4491733 0.79 SMN1; SMN2 (0.46) SPHK1SCN3APOLBMAOAMAOB
SCHEMBL1031700 0.79 SMN1; SMN2 (0.46) SPHK1SCN3APOLBMAOAMAOB
SCHEMBL1530965 0.79 SMN1; SMN2 (0.46) SPHK1SCN3APOLBMAOAMAOB
SCHEMBL6523272 0.78 SMN1; SMN2 (0.40) POLBLMNASMN1; SMN2
Hydrochloric Acid SCHEMBL3970845 0.78 SMN1; SMN2 (0.44) SPHK1SCN3APOLBMAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3340981-A1 ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS Achillion Pharmaceuticals, Inc. (US) 2018-07-04 EP disclosed
WO-2017035353-A1 ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS ACHILLION PHARMACEUTICALS, INC. (US) 2017-03-02 WO disclosed